Theranostics continue to gain momentum

Theranostics continue to gain momentum
Theranostics continue to gain momentum

First article in collaboration with DOTmed.com, Inc. Discover more about how Radiotheranostics continue to gain momentum, by Richard Zimmermann, founder of the Oncidium foundation.

“[…] theranostics will not only reduce considerably the patient population needed to complete the trials and, of course, the costs of drug development, but also reduce the healthcare expenses by limiting the application of expensive drugs to those who will really benefit from it.[…]”

>> Read the article

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here